Pharmacyclics Mulls Sale of Company -Bloomberg
February 25 2015 - 1:36PM
Dow Jones News
Pharmacyclics Inc. (PCYC), a developer of cancer treatments, is
considering a sale and has attracted interest from potential
suitors including Johnson & Johnson (JNJ) and Novartis AG
(NVS), Bloomberg News reported Wednesday, citing people with
knowledge of the matter.
The company's shares were recently up 19% to $224.32.
Full story at:
www.bloomberg.com/news/articles/2015-02-25/pharmacyclics-said-to-weigh-sale-of-15-billion-u-s-drugmaker
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024